Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5902034 | Journal of Diabetes and its Complications | 2016 | 34 Pages |
Abstract
The combined therapy of Exenatide and MET shows better therapeutic results in female patients than in male patients. Therefore, the dual therapy is more suitable for female patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Huibiao Quan, Huachuan Zhang, Weiping Wei, Tuanyu Fang,